Susquehanna International Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110M Buy
375,200
+27,400
+8% +$9.01M 0.01% 770
2025
Q4
$122M Sell
347,800
-79,700
-19% -$26.9M 0.01% 762
2025
Q3
$138M Buy
427,500
+87,100
+26% +$27.1M 0.02% 704
2025
Q2
$132M Buy
340,400
+51,600
+18% +$20.8M 0.02% 611
2025
Q1
$126M Buy
288,800
+13,100
+5% +$5.26M 0.02% 556
2024
Q4
$102M Buy
275,700
+105,800
+62% +$44.3M 0.02% 701
2024
Q3
$88.3M Buy
169,900
+33,700
+25% +$18M 0.02% 709
2024
Q2
$73.8M Buy
136,200
+8,100
+6% +$4.28M 0.01% 748
2024
Q1
$66.4M Sell
128,100
-164,200
-56% -$81.7M 0.01% 865
2023
Q4
$138M Buy
292,300
+11,200
+4% +$5.18M 0.03% 549
2023
Q3
$122M Sell
281,100
-8,300
-3% -$3.76M 0.03% 529
2023
Q2
$129M Sell
289,400
-11,800
-4% -$5.44M 0.03% 498
2023
Q1
$138M Buy
301,200
+50,900
+20% +$24.2M 0.03% 476
2022
Q4
$128M Sell
250,300
-71,900
-22% -$36.5M 0.03% 458
2022
Q3
$146M Buy
322,200
+95,100
+42% +$45.5M 0.04% 386
2022
Q2
$110M Buy
227,100
+17,800
+9% +$8.81M 0.03% 494
2022
Q1
$103M Sell
209,300
-16,100
-7% -$7.36M 0.02% 648
2021
Q4
$104M Sell
225,400
-315,200
-58% -$133M 0.02% 695
2021
Q3
$202M Buy
540,600
+141,100
+35% +$53.6M 0.03% 515
2021
Q2
$153M Sell
399,500
-152,700
-28% -$58.4M 0.02% 619
2021
Q1
$198M Sell
552,200
-67,000
-11% -$21.5M 0.03% 448
2020
Q4
$199M Sell
619,200
-24,600
-4% -$7.55M 0.03% 420
2020
Q3
$173M Sell
643,800
-50,100
-7% -$13.5M 0.03% 381
2020
Q2
$182M Buy
693,900
+34,800
+5% +$9.28M 0.04% 321
2020
Q1
$150M Buy
659,100
+83,100
+14% +$22.6M 0.05% 282
2019
Q4
$174M Sell
576,000
-190,200
-25% -$52.3M 0.05% 314
2019
Q3
$184M Buy
766,200
+268,400
+54% +$73.5M 0.06% 261
2019
Q2
$140M Buy
497,800
+145,300
+41% +$39.7M 0.05% 314
2019
Q1
$101M Buy
352,500
+133,000
+61% +$38.5M 0.04% 372
2018
Q4
$57.6M Sell
219,500
-20,400
-9% -$5.61M 0.02% 553
2018
Q3
$65.7M Buy
239,900
+78,400
+49% +$20.4M 0.02% 574
2018
Q2
$38.4M Sell
161,500
-42,100
-21% -$9.75M 0.01% 824
2018
Q1
$44.7M Sell
203,600
-253,200
-55% -$59.5M 0.02% 713
2017
Q4
$103M Sell
456,800
-60,200
-12% -$12.8M 0.04% 413
2017
Q3
$98.2M Buy
517,000
+99,000
+24% +$18.8M 0.04% 387
2017
Q2
$78.6M Sell
418,000
-82,600
-17% -$14.8M 0.03% 420
2017
Q1
$82.8M Buy
500,600
+700
+0.1% +$111K 0.04% 390
2016
Q4
$71.9M Sell
499,900
-74,300
-13% -$9.95M 0.04% 422
2016
Q3
$72M Buy
574,200
+111,000
+24% +$14.3M 0.03% 408
2016
Q2
$60.8M Buy
463,200
+121,400
+36% +$16.6M 0.03% 448
2016
Q1
$47.5M Buy
341,800
+65,700
+24% +$8.78M 0.03% 545
2015
Q4
$38.5M Sell
276,100
-172,400
-38% -$23.7M 0.02% 739
2015
Q3
$62.8M Sell
448,500
-469,500
-51% -$70.6M 0.03% 516
2015
Q2
$151M Buy
918,000
+527,600
+135% +$84.3M 0.06% 271
2015
Q1
$60.3M Sell
390,400
-271,700
-41% -$38.7M 0.03% 551
2014
Q4
$83.2M Sell
662,100
-91,000
-12% -$11.2M 0.03% 482
2014
Q3
$90.1M Sell
753,100
-2,200
-0.3% -$252K 0.03% 448
2014
Q2
$81.3M Buy
755,300
+29,200
+4% +$3.01M 0.04% 451
2014
Q1
$72.3M Sell
726,100
-85,600
-11% -$7.74M 0.03% 468
2013
Q4
$75M Buy
811,700
+126,200
+18% +$11.2M 0.03% 465
2013
Q3
$57.3M Buy
685,500
+86,400
+14% +$7.4M 0.03% 539
2013
Q2
$49M Buy
+599,100
New +$44.8M 0.03% 567

Other funds holding ELV

Susquehanna International Group's ELV Position: Q1 2026 in Review

Susquehanna International Group increased its Elevance Health (ELV) stake by 17% in Q1 2026, buying an estimated $7.29M and bringing the position to 150,529 shares worth $44.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Susquehanna International Group first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $92.8M in Q2 2023. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Susquehanna International Group held 150,529 shares of Elevance Health worth $44.1M as of Q1 2026.
  • Susquehanna International Group bought 22,176 Elevance Health shares in Q1 2026, an estimated $7.29M.
  • Elevance Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1391 holding.
  • Susquehanna International Group first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Elevance Health position peaked at $92.8M in Q2 2023.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.